ArticleThe Journal of biological chemistry2017

Sorafenib targets the mitochondrial electron transport chain complexes and ATP synthase to activate the PINK1-Parkin pathway and modulate cellular drug response.

Conggang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.